Nektar Therapeutics (NASDAQ:NKTR) currently has a daily average trading volume of 1.67M but it saw 1620030 shares traded in last market. With a market cap of 434.24M USD, the company’s current market price of $25.1 came rising about 7.45 while comparing to the previous closing price of $23.36. In past 52 weeks, the stock remained buoying in the range of price level as high as $37.38 and as low as $6.48. In the recent trading on the day, stock has struck highest price mark of $22.6706 while lowest mark touched by it was $25.57.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the H.C. Wainwright which reiterated the stock as “Buy” in its note to investors issued on June 24, 2025, recommending a price target of between $6.50 and $120 for it. Jefferies issued its recommendations for the stock as it upgraded the price target for the stock is $2.
Over the week, NKTR’s stock price is moving -1.68% down while it is 185.55% when we observe its performance for the past one month. Year-to-date it is 34.95% up and over the past year, the stock is showing an upside performance of 79.93%.
Currently, Nektar Therapeutics’s total number of outstanding shares is 17.30M. Company’s return on investment (ROI) stands at -74.51% and return on equity (ROE) at -189.46%. Stock’s beta reads 0.98. Stock has a price to book (P/B) ratio of 22.67 while price to sale or P/S ratio amounts to 4.98. Its return on asset (ROA) is -40.79% on average.
